If you are wondering whether Nuvation Bio's share price lines up with its underlying value, the recent action in the stock gives you plenty to think about. The shares last closed at US$4.22, with ...
Longleaf Partners, managed by Southeastern Asset Management, released its fourth-quarter 2025 investor letter for “Longleaf ...
Investing.com -- Biohaven Ltd. (NYSE:BHVN) shares rose 2% Thursday after the company announced full enrollment in its Phase 2 study evaluating taldefgrobep alfa for obesity treatment, with topline ...
On March 2, the U.S. Environmental Protection Agency’s (EPA’s) final effluent limitations guidelines (ELG) Deadline ...
Company to host conference call and webcast today at 8:00 a.m. EDT The European Commission (EC) approved the 2mg/kg every-4-weeks (E4W) dosing regimen for Elfabrio® ...
Less like a Ferrari and more like a junkyard go-kart, the arrangements of organs within our vertebrate bodies are far from well-ordered. This is especially true of our internal wiring, specifically ...
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. engages in the research and development, manufacturing, marketing and service of medical devices. It products include patient monitoring, ultrasound, ...
Instant Analysis To Patriots Adding Much-Needed Depth In Form Of K.J. Britt originally appeared on NESN. Add NESN as a ...
Results demonstrated early signals of C-peptide preservation T1D key opinion leader, Michael J. Haller, MD, provided a recorded webinar reviewing the SAB-142 Phase 1 data MIAMI, March 10, 2026 (GLOBE ...
Protalix Biotherapeutics Inc (NYSE-A:PLX, FRA:PBDA) announced that the European Commission has approved a new dosing regimen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results